Dosage and Usage Flashcards
1
Q
Administration
A
Administer as an intravenous infusion over 60 minutes
2
Q
Unresectable or metastatic melanoma monotherapy
A
OPDIVO 240mg every 2 weeks.
3
Q
Unresectable or metastatic melanoma regimen
A
OPDIVO with ipilimumab: OPDIVO 1 mg/kg, followed by ipilimumab on the same day, every 3 weeks for 4 doses, then OPDIVO 240mg every 2 weeks.
4
Q
Metastatic non-small cell lung cancer
A
OPDIVO 240mg every 2 weeks.
5
Q
Advanced renal cell carcinoma
A
OPDIVO 240mg every 2 weeks.
6
Q
Classical Hodgkin Lymphoma
A
OPDIVO 3 mg/kg every 2 weeks.
7
Q
Dosage forms and strengths
A
Injection: 40 mg/4 mL and 100 mg/10 mL solution in a single-dose vial.